Consider patients who present with symptoms of anemia. Clinicians confer the highest importance to hemoglobin (Hgb) measurement. This is because this parameter can directly reflect patient quality of life, independent of any underlying disease that may cause the anemia. Hence, there is a need for quality assurance (QA) measures that ensure Hgb testing reliability. The “rule of three” contributes largely to this end.
Join Dr. Ahmed Bentahar, senior manager, global scientific marketing at Beckman Coulter, for a discussion about a more robust method of red blood cell (RBC) testing and analysis that can yield higher quality results. After this webinar, you will be able to:
- Use the “rule of three” to combat spurious RBC results
- Improve the quality of RBC testing and analysis by combining hematocrit and hemoglobin parameters
- Measure RBCs in their native states more precisely to support better patient care
P.A.C.E. credit is available for your participation.*
Presenter: Ahmed Bentahar, M.D., Ph.D.
Dr. Bentahar is a clinical analysis specialist (pathologist) with more than 30 years of experience in the field of hematology and laboratory medicine. For the past 27 years, he served as a hematology product specialist, hematology product manager, staff applications scientist and senior manager of global scientific marketing at Beckman Coulter. Dr. Bentahar received his M.D. and Ph.D. from État de Liège University, Belgium, and his master’s degree in health management and leadership from the European Institute of Health and Social Wellbeing, Madrid, Spain. As a member of the Sociedad Española de Hematología y Hemoterapia (SEHH) and Asociación Española de Biopatología Médica (AEBM), Dr. Bentahar has earned international recognition as a respected thought leader and uniquely qualified facilitator of hematology industry seminars, workshops and congresses.